View More Recent Stories

May 23, 2018 12:21AM Sun Pharma Announces USFDA Approval of YONSA® (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone
Mar 21, 2018 09:04AM Sun Pharma Announces U.S. FDA Approval of ILUMYA™ (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
Feb 12, 2018 08:12AM Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting
Sep 20, 2017 07:27AM Sun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of Response of 26 Months in Treatment of Locally Advanced Basal Cell Carcinoma
Jul 4, 2017 12:27AM Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab
May 24, 2017 08:03AM Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application (BLA) For Tildrakizumab
Mar 1, 2017 10:35AM Sun Pharma Announces Data from Tildrakizumab Clinical Development Program to be Presented at the 2017 American Academy of Dermatology Meeting
Dec 12, 2016 06:37AM Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis
Oct 1, 2016 05:05AM Sun Pharma to Announce Late-Breaking Results for Investigational IL-23p19 inhibitor, Tildrakizumab, Achieves Primary End Point in Both Phase-3 Studies in Patients with Moderate-to-Severe Plaque Psoria
Aug 8, 2016 09:00AM Sun Pharma Extends Imatinib Mesylate Savings Card Program Benefits for Patients in USA
Jul 27, 2016 01:59PM Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis
Jul 24, 2015 06:00AM Even Companies Facing Strong Economic Headwinds Can Deliver Superior Shareholder Value
Jul 6, 2015 07:00AM Horizon Pharma plc Files Patent Infringement Lawsuits Against Five Companies for Filing Abbreviated New Drug Applications for PENNSAID(R) (Diclofenac Sodium Topical Solution) 2%
View More Recent Stories